IP Library › Assignment 070204/0035
Patent Assignment
Reel/Frame 070204/0035

Release of Security Interest

Recorded: 2025-02-13 Pages: 7
Assignor
Assignee
MARINUS PHARMACEUTICALS, INC.
5 RADNOR CORPORATE CENTER, 100 MATSONFORD ROAD, SUITE 500, RADNOR, PENNSYLVANIA, 19087
Covered Properties (31)
Solid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 7,858,609 →
Application: 11/606,222 →
Publication: US 2007/0148252
Liquid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 8,022,054 →
Application: 11/605,700 →
Publication: US 2007/0141161
Solid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 8,367,651 →
Application: 13/052,798 →
Publication: US 2011/0236487
Liquid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 8,318,714 →
Application: 13/217,384 →
Publication: US 2012/0052098
Liquid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 9,056,116 →
Application: 13/657,135 →
Publication: US 2013/0287851
Solid Ganaxolone Formulations and Methods for the Making and Use Thereof
Patent: 8,618,087 →
Application: 13/719,640 →
Publication: US 2013/0156821
Solid Ganaxolone Compositions and Methods for the Making and Use Thereof
Patent: 9,029,355 →
Application: 14/087,903 →
Publication: US 2014/0154309
Solid Ganaxolone Compositions and Methods for the Making and Use Thereof
Patent: 9,452,176 →
Application: 14/709,062 →
Publication: US 2015/0313843
Method of Treatment Using Nanoparticulate Ganaxolone Formulations
Application: 16/149,970 →
Publication: US 2019/0117674
Method for Making 3A-Hydroxy, 3B- Substituted-5A-Pregnan-20-Ones
Patent: 8,362,286 →
Application: 12/854,226 →
Publication: US 2011/0040112
Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders
Application: 17/854,448 →
Injectable Neurosteroid Formulations Containing Nanoparticles
Application: 15/294,135 →
Publication: US 2017/0258812
Injectable Neurosteroid Formulations Containing Nanoparticles
Application: 16/992,873 →
Publication: US 2021/0128583
Injectable Neurosteroid Formulations Containing Nanoparticles
Application: 17/854,437 →
Methods of Treating Certain Depressive Disorders and Delirium Tremens
Application: 15/700,314 →
Publication: US 2018/0071315
Methods of Treating Certain Depressive Disorders and Delirium Tremens
Application: 16/150,782 →
Publication: US 2019/0167698
Methods of Treating Certain Depressive Disorders and Delirium Tremens
Application: 16/829,661 →
Publication: US 2020/0289530
Ganaxolone for Use in Treating Genetic Epileptic Disorders
Application: 17/681,001 →
Ganaxolone for Use in Treating Genetic Epileptic Disorders
Application: 17/703,331 →
Publication: US 2022/0249515
Ganaxolone for Use in Prophylaxis and Treatment of Pospartum Depression
Application: 16/705,541 →
Publication: US 2020/0179403
Ganaxolone for Use in Treatment of Status Epilepticus
Application: 17/186,569 →
Publication: US 2021/0186987
Ganaxolone for Use in Treatment of Status Epilepticus
Application: 17/393,566 →
Publication: US 2022/0202831
Ganaxolone for Use in Treatment of Status Epilepticus
Application: 17/729,427 →
Publication: US 2022/0265680
Ganaxolone for Use in Treating Tuberous Sclerosis Complex
Application: 17/683,624 →
Publication: US 2022/0211723
Prodrugs of Ganaxolone
Application: 63/321,302 →
Prodrugs of Ganaxolone
Application: 63/392,878 →
Ganaxolone for Use in Treatment of Super Refractory Status Epilepticus
Use of Ganaxolone in Treating an Epilepsy Disorder
Amorphous Solid Dispersion Ganaxolone Formulation
Ganaxolone for Use in Treating Tuberous Sclerosis Complex and Seizure Disorders
Ganaxolone for Use in Treatment of Established Status Epilepticus
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 28, 2006
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 018638/0982 →
Assignment of Assignor's Interest Nov 29, 2006
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 018630/0213 →
Assignment of Assignor's Interest Sep 17, 2010
From: SHAW, KENNETH; HUTCHISON, ALAN
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 025004/0272 →
Assignment of Assignor's Interest Oct 3, 2012
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 029071/0854 →
Assignment of Assignor's Interest Jan 9, 2013
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 029592/0851 →
Assignment of Assignor's Interest Mar 17, 2014
From: KENNETH, SHAW; MINGBAO, ZHANG
To: MARINUS PHARMACEUTICALS
Reel/Frame 032452/0914 →
Assignment of Assignor's Interest Nov 2, 2015
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 036938/0243 →
Assignment of Assignor's Interest Nov 2, 2015
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 036937/0986 →
Assignment of Assignor's Interest Nov 2, 2015
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS
Reel/Frame 036938/0189 →
Assignment of Assignor's Interest Nov 16, 2016
From: ZHANG, MINGBAO; GLOWAKY, RAYMOND C.; CZEKAI, DAVID
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 040340/0312 →
Assignment of Assignor's Interest Jun 19, 2018
From: CASHMAN, CHRISTOPHER; LAPPALAINEN, JAAKKO; CZEKAI, DAVID A.
To: MARINUS PHARMACEUTICALS INC.
Reel/Frame 046132/0787 →
Assignment of Assignor's Interest Feb 26, 2020
From: AIMETTI, ALEX; CASHMAN, CHRISTOPHER; MASUOKA, LORIANNE; LAPPALAINEN, JAAKKO
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 051941/0460 →
Assignment of Assignor's Interest Mar 20, 2020
From: CASHMAN, CHRISTOPHER; LAPPALAINEN, JAAKKO; CZEKAI, DAVID A.
To: MARINUS PHARMACEUTICALS INC.
Reel/Frame 052177/0703 →
Assignment of Assignor's Interest Jun 3, 2020
From: CASHMAN, CHRISTOPHER; LAPPALAINEN, JAAKKO; CZEKAI, DAVID A.
To: MARINUS PHARMACEUTICALS INC.
Reel/Frame 052827/0472 →
Assignment of Assignor's Interest Jan 6, 2021
From: ZHANG, MINGBAO; GLOWAKY, RAYMOND C.; CZEKAI, DAVID
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 054832/0494 →
Security Interest May 11, 2021
From: MARINUS PHARMACEUTICALS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 056206/0266 →
Assignment of Assignor's Interest Jun 21, 2021
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 056608/0740 →
Corrective Assignment to Correct the Receiving Party Should Be Marinus Pharmaceuticals, Inc. Previously Recorded at Reel: 029071 Frame: 0854. Assignor(S) Hereby Confirms the Assignment. Feb 28, 2022
From: SHAW, KENNETH; ZHANG, MINGBAO
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 059618/0570 →
Assignment of Assignor's Interest Feb 28, 2022
From: LAPPALAINEN, JAAKKO; MASUOKA, LORIANNE K.
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 059117/0670 →
Assignment of Assignor's Interest Jun 3, 2022
From: LAPPALAINEN, JAAKKO; MASUOKA, LORIANNE K
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 060095/0625 →
Assignment of Assignor's Interest Aug 8, 2022
From: ZHANG, MINGBAO; GLOWAKY, RAYMOND C.
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 060748/0809 →
Assignment of Assignor's Interest Aug 8, 2022
From: ZHANG, MINGBAO; GLOWAKY, RAYMOND C.; CZEKAI, DAVID
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 060748/0864 →
Security Interest Oct 28, 2022
From: MARINUS PHARMACEUTICALS, INC.
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP
Reel/Frame 061580/0171 →
Release of Security Interest Feb 20, 2025
From: OAKTREE FUND ADMINISTRATION, LLC
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 070278/0496 →
Change of Name May 14, 2025
From: MARINUS PHARMACEUTICALS, INC.
To: IMMEDICA PHARMA US INC.
Reel/Frame 071116/0534 →